Impact of COVID-19 in patients with multiple myeloma based on a global data network

Impact of COVID-19 in patients with multiple myeloma based on a global data network

Abstract The COVID-19 pandemic has represented a major cause of morbidity/mortality worldwide, overstressing health systems. Multiple myeloma (MM) patients show an increased risk for infections and they are expected to be particularly vulnerable to SARS-CoV-2 infection. Here we have obtained a compr...

Full description

Bibliographic Details
Main Authors:	J. Martinez-Lopez, G. Hernandez-Ibarburu, R. Alonso, J. M. Sanchez-Pina, I. Zamanillo, N. Lopez-Muñoz, Rodrigo Iñiguez, C. Cuellar, M. Calbacho, M. L. Paciello, R. Ayala, N. García-Barrio, D. Perez-Rey, L. Meloni, J. Cruz, M. Pedrera-Jiménez, P. Serrano-Balazote, J. de la Cruz
Format:	Article
Language:	English
Published:	Nature Publishing Group 2021-12-01
Series:	Blood Cancer Journal
Online Access:	https://doi.org/10.1038/s41408-021-00588-z

Similar Items

P928: REAL-LIFE ANALYSIS OF THE MULTIPLE MYELOMA PATIENT’S SURVIVAL IN A LARGE COHORT OF PATIENTS
by: N. Lopez-Muñoz, et al.
Published: (2022-06-01)

Large-scale real-life analysis of survival and usage of therapies in multiple myeloma
by: N. Lopez-Muñoz, et al.
Published: (2023-07-01)

Correction: Large-scale real-life analysis of survival and usage of therapies in multiple myeloma
by: N. Lopez-Muñoz, et al.
Published: (2023-07-01)

P716: OUTCOMES AND PATTERNS OF TREATMENT IN CHRONIC MYELOID LEUKEMIA, A GLOBAL PERSPECTIVE BASED ON A REAL-WORLD DATA GLOBAL NETWORK
by: A. Sanz, et al.
Published: (2022-06-01)

Outcomes and patterns of treatment in chronic myeloid leukemia, a global perspective based on a real-world data global network
by: A. Sanz, et al.
Published: (2022-06-01)

P948: REAL-WORLD EVIDENCE OF BISPHOSPHONATES FOR MULTIPLE MYELOMA
by: Maria Nieves Lopez Muñoz, et al.
Published: (2023-08-01)

Clinical Outcomes of Patients with Multiple Myeloma after Daratumumab Failure
by: Irene Zamanillo, et al.
Published: (2023-08-01)

P1328: SUCCESFUL TREATMENT OF GRAFT FAILURE IN AUTOLOGOUS STEM CELL TRANSPLANTATION WITH CYCLOSPORINE
by: D. Cubillas, et al.
Published: (2022-06-01)

P845: IDENTIFICATION OF MULTIPLE MYELOMA BIOMARKERS VIA LIQUID BIOPSY BASED ON CELL-FREE DNA USING A CAPTURE-HYBRIDIZATION PANEL
by: N. Buenache Cuenda, et al.
Published: (2022-06-01)

PB2091: INFLUENCE OF HISTOLOGICAL GRADE IN CLINICAL CHARACTERISTICS AND LONG-TERM OUTCOME OF FOLICULAR LYMPHOMA
by: I. Zamanillo, et al.
Published: (2022-06-01)

P1132: PET INTERIM RESULTS PREDICT PROGRESSION-FREE-SURVIVAL IN FOLLICULAR LYMPHOMA PATIENTS WITH ADVANCED STAGE
by: M. Poza, et al.
Published: (2022-06-01)

Can OpenEHR, ISO 13606, and HL7 FHIR Work Together? An Agnostic Approach for the Selection and Application of Electronic Health Record Standards to the Next-Generation Health Data Spaces
by: Miguel Pedrera-Jiménez, et al.
Published: (2023-12-01)

An Ontology-Based Approach for Consolidating Patient Data Standardized With European Norm/International Organization for Standardization 13606 (EN/ISO 13606) Into Joint Observational Medical Outcomes Partnership (OMOP) Repositories: Description of a Methodology
by: Santiago Frid, et al.
Published: (2023-03-01)

Myeloma-induced alloreactive T cells arising in Myeloma-infiltrated bones include double-positive CD8(+)CD4(+) T cells: evidence from myeloma-bearing mouse model
by: Freeman, L.M., et al.
Published: (2011)

CHARACTERIZATION OF MULTIPLE MYELOMA PATIENTS THROUGH FLOW CYTOMETRY AND CYTOGENETIC STUDIES 2013 – 2018
by: J.M. Gil-Ramos, et al.
Published: (2020-11-01)

Lifestyle considerations in multiple myeloma
by: Yael N. Shapiro, et al.
Published: (2021-10-01)

P1368: OUTPATIENT AUTOTRANSPLANTS FOR PERSONS WITH MULTIPLE MYELOMA
by: J. M. Sánchez-Raga, et al.
Published: (2022-06-01)

PB1993: MULTIPLE MYELOMA BRAZILIAN REGISTER- HOW ABOUT THE TRANSPLANT ELIGIBLE PATIENTS?
by: E. Crusoe, et al.
Published: (2022-06-01)

Ibrutinib effect in acquired von Willebrand syndrome secondary to Waldenström macroglobulinemia
by: María Poza, et al.
Published: (2021-08-01)

PB1974: MULTIVARIATE SPECTRAL BIOTYPING OF EXTRAMEDULLARY MULTIPLE MYELOMA
by: M. Vlachová, et al.
Published: (2022-06-01)

Lenalidomide for relapsed or refractory multiple myeloma
by: S. S. Bessmeltsev1, et al.
Published: (2014-07-01)

Lenalidomide for relapsed or refractory multiple myeloma
by: S. S. Bessmeltsev1, et al.
Published: (2014-07-01)

The clinical significance of stringent complete response in multiple myeloma is surpassed by minimal residual disease measurements.
by: Maria-Teresa Cedena, et al.
Published: (2020-01-01)

Protein profiling in myeloma in vivo; Effects of bortezomib in a mouse model of myeloma
by: Edwards, C, et al.
Published: (2007)

MYELOMATOUS PLEURAL EFFUSION IN MULTIPLE MYELOMA DIAGNOSED BY FLOW CYTOMETRY: CASE REPORTS OF A RARE CONDITION
by: J.M. Bonete, et al.
Published: (2020-11-01)

Expressed fusion gene landscape and its impact in multiple myeloma
by: A. Cleynen, et al.
Published: (2017-12-01)

Myeloma‐induced leucocytoclastic vasculitis
by: Kanchana De Abrew, et al.
Published: (2020-07-01)

T‐cell pseudolymphoma secondary to ixazomib for multiple myeloma
by: M. Haq, et al.
Published: (2021-09-01)

Maxilla osseus sequestre and oral exposure: effects of the treatment of multiple myeloma with bisphosphonates.
by: J V Lobato, et al.
Published: (2007-04-01)

P863: GENERATION OF A FIRST-IN-CLASS INHIBITOR FOR THE MASTER ONCOREGULATOR HNRNP K IN MULTIPLE MYELOMA
by: Á. Otero Sobrino, et al.
Published: (2022-06-01)

S170: DYNAMIC INTERPLAY BETWEEN TUMOR AND MICRO-ENVIRONMENT DURING MYELOMA DISEASE PROGRESSION
by: M. C. Köse, et al.
Published: (2022-06-01)

Myeloma /
by: 455001 Tanner, Jerome E., et al.
Published: (2008)

IS THE INCIDENCE OF MULTIPLE-MYELOMA REALLY INCREASING
by: Velez, R, et al.
Published: (1981)

Genomic patterns of progression in smoldering multiple myeloma
by: Bolli, N, et al.
Published: (2018)

DARATUMUMAB FOR THE TREATMENT OF MULTIPLE MYELOMA
by: V. V. Ryzhko, et al.
Published: (2017-11-01)

Comorbidities in patients with multiple myeloma
by: L. P. Kuznetsova, et al.
Published: (2019-08-01)

Anti-tumour activity of bisphosphonates in human myeloma cells.
by: Shipman, C, et al.
Published: (1998)

BRAZILIAN REAL-WORLD MULTIPLE MYELOMA (MM) ELECTRONIC PLATFORM REGISTER PROJECT
by: E.Q. Crusoé, et al.
Published: (2020-11-01)

P1430: GUT MICROBIOTA DIVERSITY AND BUTYRATE PRODUCERS IMPACTS ON NON-HODGKIN LYMPHOMA PATIENTS RESPONSE TO CD19 CAR-T THERAPY
by: R. Garcia-Vicente, et al.
Published: (2022-06-01)

Arterial thromboembolism in multiple myeloma in the context of modern anti-myeloma therapy
by: Rajshekhar Chakraborty, et al.
Published: (2021-06-01)